These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20547733)

  • 1. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice.
    Kaichi S; Hasegawa K; Takaya T; Yokoo N; Mima T; Kawamura T; Morimoto T; Ono K; Baba S; Doi H; Yamanaka S; Nakahata T; Heike T
    Cardiovasc Res; 2010 Nov; 88(2):314-23. PubMed ID: 20547733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of human induced pluripotent stem cells from cord blood cells.
    Nishishita N; Takenaka C; Fusaki N; Kawamata S
    J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.
    Koyanagi M; Iwasaki M; Rupp S; Tedesco FS; Yoon CH; Boeckel JN; Trauth J; Schütz C; Ohtani K; Goetz R; Iekushi K; Bushoven P; Momma S; Mummery C; Passier R; Henschler R; Akintuerk H; Schranz D; Urbich C; Galvez BG; Cossu G; Zeiher AM; Dimmeler S
    Circ Res; 2010 Apr; 106(7):1290-302. PubMed ID: 20185800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem (iPS) cell research overview.
    Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
    Heffernan C; Sumer H; Verma PJ
    J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotency with endogenous and inducible genes.
    Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
    Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo differentiation of induced pluripotent stem cells into male germ cells.
    Cai H; Xia X; Wang L; Liu Y; He Z; Guo Q; Xu C
    Biochem Biophys Res Commun; 2013 Apr; 433(3):286-91. PubMed ID: 23524261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
    Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
    Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
    Meissner A; Wernig M; Jaenisch R
    Nat Biotechnol; 2007 Oct; 25(10):1177-81. PubMed ID: 17724450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
    Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
    Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging methods for preparing iPS cells.
    Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
    Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse induced pluripotent stem cells.
    Geoghegan E; Byrnes L
    Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
    Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
    Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.